Evidence map›Paper›PMID 26205529›Full record

ArticleActa neuropathologica communications2015

Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathy.

Alessandra Ruggieri, Francesco Brancati, Simona Zanotti, Lorenzo Maggi, Maria Barbara Pasanisi, Simona Saredi, Chiara Terracciano, Carlo Antozzi, Maria Rosaria D Apice, Federica Sangiuolo and 8 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. DnaJC7 specifically regulates tau seeding.bioRxiv : the preprint server for biology · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Panorama of the distal myopathies.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Alessandra RuggieriNeuromuscular Disease and Immunology Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Via Celoria 11, 20133, Milan, Italy.
Francesco BrancatiMedical Genetics Unit, Policlinico Tor Vergata University Hospital, Rome, Italy.
Simona ZanottiNeuromuscular Disease and Immunology Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Via Celoria 11, 20133, Milan, Italy.
Lorenzo MaggiNeuromuscular Disease and Immunology Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Via Celoria 11, 20133, Milan, Italy.
Maria Barbara PasanisiNeuromuscular Disease and Immunology Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Via Celoria 11, 20133, Milan, Italy.
Simona SarediNeuromuscular Disease and Immunology Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Via Celoria 11, 20133, Milan, Italy.
Chiara TerraccianoDepartment of Systems Medicine (Neurology), Neuromuscular Disease Unit, University of Rome Tor Vergata, Rome, Italy.
Carlo AntozziNeuromuscular Disease and Immunology Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Via Celoria 11, 20133, Milan, Italy.
Maria Rosaria D ApiceMedical Genetics Unit, Policlinico Tor Vergata University Hospital, Rome, Italy.
Federica SangiuoloMedical Genetics Unit, Policlinico Tor Vergata University Hospital, Rome, Italy.
Giuseppe NovelliMedical Genetics Unit, Policlinico Tor Vergata University Hospital, Rome, Italy.
Christian R MarshallThe Centre for Applied Genomics and Program in Genetics and Genome Biology, The Hospital for Sick Children and University of Toronto, Toronto, Canada.
Stephen W SchererThe Centre for Applied Genomics and Program in Genetics and Genome Biology, The Hospital for Sick Children and University of Toronto, Toronto, Canada.
Lucia MorandiNeuromuscular Disease and Immunology Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Via Celoria 11, 20133, Milan, Italy.
Luca FedericiDepartment of Medical, Oral and Biotechnological Sciences, University of Chieti "G. d'Annunzio", Chieti, Italy.
Roberto MassaDepartment of Systems Medicine (Neurology), Neuromuscular Disease Unit, University of Rome Tor Vergata, Rome, Italy.
Marina MoraNeuromuscular Disease and Immunology Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Via Celoria 11, 20133, Milan, Italy. marina.mora@istituto-besta.it.
Berge A MinassianThe Centre for Applied Genomics and Program in Genetics and Genome Biology, The Hospital for Sick Children and University of Toronto, Toronto, Canada. berge.minassian@sickkids.ca.
Fondazione IRCCS Istituto Neurologico Carlo Besta · ITUniversity of Rome Tor Vergata · ITPoliclinico Tor Vergata · ITSickKids Foundation · CAUniversity of Toronto · CAUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionProtein aggregation is a common cause of neuropathology. The protein aggregation myopathy Limb-Girdle Muscular Dystrophy 1D (LGMD1D) is caused by mutations of amino acids Phe89 or Phe93 of DNAJB6, a co-chaperone of the HSP70 anti-aggregation protein. Another DNAJB6 mutation, Pro96Arg, was found to cause a distal-onset myopathy in one family.

resultsWe detail the mutational, neuropathological, neurophysiological, neurological and radiological features of five new DNAJB6-myopathy families. One has the known Phe93Leu mutation and classic late-onset slowly progressive LGMD1D. Two have different mutations of Phe91 causing a variant childhood-onset severe limb-girdle myopathy. One has a Phe100Val mutation and distal-onset myopathy, unique early bulbar involvement, and a gender-modified wide age-of-onset range. The last has childhood-onset severe distal-onset myopathy and the first non-missense DNAJB6 mutation, c.346 + 5G > A, causing a splicing defect that entirely eliminates DNAJB6's G/F domain (ΔG/F), the domain that harbours all other mutations. Clinical and imaging examinations reveal that muscles considered uninvolved in DNAJB6-myopathy, e.g. lateral gastrocnemii, are affected in our patients with new mutations. Mutational modelling based on the known structure of the bacterial DNAJ2 protein indicates that all past and present mutated residues cluster within 15 Å in the G/F domain and all disturb the interface of this domain with the protein's J domain that confers the interaction with HSP70.

conclusionsOur patients expand the phenotypic spectrum of DNAJB6-myopathy and allow tentative genotype-phenotype specifications. Combining with previous studies, the clinical severity spectrum is as follows: ΔG/F and Phe91 mutations, most severe; Phe100, Pro96, Phe89 mutations, intermediate; and Phe93, least severe. As it stands presently, proximal G/F domain mutations (Phe89, Phe91, Phe93) cause proximal limb-girdle myopathy, while distal G/F mutations (Pro96, Phe100) cause distal-onset myopathy. While all mutations affect the G/F-J interaction, each likely does so in different unknown extents or ways. One mutation, ΔG/F, causes its associated severe distal-onset myopathy phenotype in a clear way, through generation of a G/F domain-lacking DNAJB6 protein.

Indexed as

AdultAgedDNA Mutational AnalysisFamily HealthFemaleGenetic Predisposition to DiseaseHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHumansItalyMaleMiddle AgedModels, MolecularMolecular ChaperonesMuscular DiseasesMutation, MissenseDNAJB6 protein, humanHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsMolecular ChaperonesNerve Tissue ProteinsPhenylalanineValine

Identifiers

PMID26205529
PMCPMC4513909
OpenAlexW2164015898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.